Utah Medical Products, Inc. (UTMD) Stock Overview
Explore Utah Medical Products, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Utah Medical Products, Inc. (UTMD)
Key Financials
Key Financials
Market Cap
227.4M
P/E Ratio
22.38
EPS (TTM)
$3.38
ROE
0.09%
UTMD Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Utah Medical Products, Inc. (NASDAQ: UTMD) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Utah Medical Products, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of UTMD on the NASDAQ shows an RSI of 54.80, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $71.10 for the NASDAQ listing.
Key metrics behind Utah Medical Products, Inc.'s NASDAQ-traded stock include a P/E ratio of 22.38 and a market capitalization of 227.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of UTMD on the NASDAQ.